The retrospective study from a team at GW found that spironolactone may be safe to treat female pattern hair loss in breast cancer survivors.
Investigators at SMHS received a $1.2 million grant from Wellcome Trust to produce a controlled human hookworm infection model and establish a hookworm vaccine challenge model for two of the most advanced hookworm vaccine candidate antigens in...
Alberto Bosque, PhD, MBA, assistant professor of microbiology, immunology, and tropical medicine, and his research team published in PLOS Pathogens finding a multiple sclerosis drug may be used to block HIV infection and reduce the latent...
Juan Reyes, MD, and Shant Ayanian, MD, both assistant professors of medicine, published research in the journal Future Medicine, finding five biomarkers associated with higher odds of clinical deterioration and death in COVID-19 patients.
Alejandro Villagra, PhD, assistant professor of biochemistry and molecular medicine, and his research team published a new study in Cancer Research, finding the genetic modifier HDAC6 controls tumor growth and halts metastasis in triple-negative...
The George Washington University will participate in a clinical trial for an investigational COVID-19 vaccine.
A recent review published by GW researchers suggests that nitric oxide has promise as a therapeutic to control the replication and rapid spread of SARS-CoV-2.
Rebecca Lynch, PhD, was awarded $3.6 million to investigate HIV-1 resistance to antibody treatments.
COVID-19 and treatment innovation headline AAKP & GW School of Medicine and Health Sciences Annual Global Summit.
Elmer E. Huerta, MD, MPH, will serve as the director of the Cancer Preventorium at the GW Cancer Center and as professor of medicine at the GW School of Medicine and Health Sciences.